MDT

96.14

-0.57%↓

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

Home・Aandelen Lijst・Pulse Biosciences Inc

Pulse Biosciences Inc

Gesloten

SectorGezondheidszorg

13.69 0.22

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

13.32

Max

13.77

Belangrijke statistieken
By Trading Economics
Inkomsten	-217K -19M
Verkoop	86K 86K
EPS	-0.29
Winstmarge	-22,540.698
Werknemers	75
EBITDA	-228K -19M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+55.48% upside

Dividenden
By Dow Jones
Volgende Winsten	26 mrt 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-179M 958M
Vorige openingsprijs	13.47
Vorige sluitingsprijs	13.69

Nieuwssentiment

By Acuity

50%

151 / 374 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

16.59 / 17.17 Steun & Weerstand

Pulse Biosciences Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

30 dec 2025, 23:49 UTC

Acquisities, Fusies, Overnames

WiseTech to Sell Expedient to Appease Competition Regulator

30 dec 2025, 17:12 UTC

Belangrijke Marktbewegers

CapsoVision Shares Rise on FDA Application for AI Tool in Swallowable Camera

30 dec 2025, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

30 dec 2025, 21:16 UTC

Acquisities, Fusies, Overnames

Penguin Solutions: Smart Modular to Sell Zilia Stake for $46M

30 dec 2025, 21:08 UTC

Marktinformatie

U.S. Natural Gas Futures Take Another Wild Ride -- Market Talk

30 dec 2025, 20:41 UTC

Marktinformatie

Oil Futures Settle Lower in Sluggish Trade -- Market Talk

30 dec 2025, 20:37 UTC

Winsten

The 5 Best Names to Play AI in 2026, According to Wall Street's Loudest Tech Bull -- Barrons.com

30 dec 2025, 19:29 UTC

Marktinformatie

Corn Extends Pullback in Light Trade -- Market Talk

30 dec 2025, 18:29 UTC

Marktinformatie

U.S. Oil Rig Count Rises By Three to 412 -- Market Talk

30 dec 2025, 17:20 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

30 dec 2025, 16:20 UTC

Winsten

Boeing Stock Is on a Roll. Why It Could Gain 25% in the Next Year. -- Barrons.com

30 dec 2025, 16:18 UTC

Acquisities, Fusies, Overnames

Meta Buys AI Startup Manus, Adding Millions of Paying Users -- 2nd Update

30 dec 2025, 16:10 UTC

Marktinformatie

Eurozone Government Bond Yields Rise, Euro Falls Ahead of Fed Minutes -- Market Talk

30 dec 2025, 15:24 UTC

Marktinformatie

Australian Dollar Could Rise Versus Sterling -- Market Talk

30 dec 2025, 15:10 UTC

Acquisities, Fusies, Overnames

Meta Stock Rises After Buying Manus. What the China-Founded AI Start-Up Brings. -- Barrons.com

30 dec 2025, 14:24 UTC

Acquisities, Fusies, Overnames

LVMH: The Three Publications Are Challenges, Sciences & Avenir, and La Recherche

30 dec 2025, 14:22 UTC

Acquisities, Fusies, Overnames

LVMH : Szafran Will Serve as Publishing Director For all Three Publications

30 dec 2025, 14:20 UTC

Acquisities, Fusies, Overnames

LVMH: As Part of the Deal, Maurice Szafran Has Been Named President of Les Editions Croque Futur

30 dec 2025, 14:17 UTC

Acquisities, Fusies, Overnames

LVMH: The Deal Also Reflects LVMH's Commitment to Support High-Quality Information and Scientific Culture

30 dec 2025, 14:16 UTC

Acquisities, Fusies, Overnames

LVMH: The Deal Aims to Accelerate the Development and Distribution of the Publications Mainly in Digital Format

30 dec 2025, 14:14 UTC

Acquisities, Fusies, Overnames

LVMH: The Move Includes Three Publications Into UFIPAR Investment Company

30 dec 2025, 14:12 UTC

Acquisities, Fusies, Overnames

LVMH: Les Editions Croque Futur Is a French Publishing House

30 dec 2025, 14:10 UTC

Acquisities, Fusies, Overnames

LVMH Acquires Les Editions Croque Futur

30 dec 2025, 13:49 UTC

Acquisities, Fusies, Overnames

Meta Buys Manus. What the China-Founded AI Start-Up Brings for Zuckerberg. -- Barrons.com

30 dec 2025, 13:36 UTC

Marktinformatie

U.S. Natural Gas Continues Weather-Driven Rally -- Market Talk

30 dec 2025, 13:30 UTC

Marktinformatie

Crude Futures Gain in Light Holiday Trade -- Market Talk

30 dec 2025, 12:55 UTC

Marktinformatie

Triple Flag Precious Metals Offers Opportunity While Mitigating Risk -- Market Talk

30 dec 2025, 11:55 UTC

Marktinformatie

Winsten

Investors Await Tesco's Profit Outlook Following U.K. Budget Reforms -- Market Talk

30 dec 2025, 11:47 UTC

Winsten

Acquisities, Fusies, Overnames

Meta's Manus Deal Is a Taster of AI Trends for 2026. Watch This Risk. -- Barrons.com

30 dec 2025, 11:35 UTC

Acquisities, Fusies, Overnames

Meta Buys Manus. What the China-Founded AI Start-Up Brings for Zuckerberg. -- Barrons.com

Peer Vergelijking

Prijswijziging

Pulse Biosciences Inc Prognose

Koersdoel

By TipRanks

55.48% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 22 USD 55.48%

Hoogste 22 USD

Laagste 22 USD

Gebaseerd op 1 Wall Street-analisten die 12-maands prijsdoelen bieden voor Pulse Biosciences Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

1 ratings

Buy

Hold

Sell

Gebaseerd op 1 analisten die aandelenratings hebben gegeven aan Pulse Biosciences Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

16.59 / 17.17Steun & Weerstand

Recent bearish events outweigh bullish events.

Sentiment

By Acuity

151 / 374 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.